New‐onset autoimmune phenomena post‐COVID‐19 vaccination

Y Chen, Z Xu, P Wang, XM Li, ZW Shuai, DQ Ye… - …, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …

CoronaVac: A review of efficacy, safety, and immunogenicity of the inactivated vaccine against SARS-CoV-2

L Jin, Z Li, X Zhang, J Li, F Zhu - Human vaccines & …, 2022 - Taylor & Francis
CoronaVac, also known as the Sinovac inactivated SARS-CoV-2 vaccine, has been widely
implemented in combating the COVID-19 pandemic. We summarized the results of clinical …

Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician …

PM Machado, S Lawson-Tovey, A Strangfeld… - Annals of the …, 2022 - ard.bmj.com
Objectives To describe the safety of vaccines against SARS-CoV-2 in people with
inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD). Methods …

Early experience of COVID‐19 vaccine‐related adverse events among adolescents and young adults with rheumatic diseases: a single‐center study

F Haslak, A Gunalp, MN Cebi, M Yildiz… - … journal of rheumatic …, 2022 - Wiley Online Library
Objective Considering the concerns regarding the coronavirus disease‐2019 (COVID‐19)
vaccine safety among pediatric patients with inflammatory rheumatic diseases (IRD) due to a …

A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and …

AG Tzioufas, AD Bakasis, AV Goules, K Bitzogli… - Journal of …, 2021 - Elsevier
Objectives To investigate humoral responses and safety of mRNA SARS-CoV-2 vaccines in
systemic autoimmune and autoinflammatory rheumatic disease (SAARD) patients subjected …

Recent advances in nanotechnology-based COVID-19 vaccines and therapeutic antibodies

L Du, Y Yang, X Zhang, F Li - Nanoscale, 2022 - pubs.rsc.org
COVID-19 has caused a global pandemic and millions of deaths. It is imperative to develop
effective countermeasures against the causative viral agent, SARS-CoV-2 and its many …

Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management

P Mehta, AY Gasparyan, O Zimba, GD Kitas - Clinical Rheumatology, 2022 - Springer
Patients with systemic lupus erythematosus (SLE) form a vulnerable group in terms of the
impact of the COVID-19 pandemic on disease management. We conducted this overview by …

COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study

GE Fragoulis, VK Bournia, E Mavrea… - Rheumatology …, 2022 - Springer
Objective To describe the rate and type of adverse effects (AEs) and the frequency of
disease flares after COVID-19 vaccination and to assess the reasons for vaccination …

Immunogenicity, effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis

KT Tang, BC Hsu, DY Chen - Biomedicines, 2022 - mdpi.com
Background: Vaccination is one of the most important measures worldwide to halt the
spread of the corona virus disease 2019 (COVID-19). However, the efficacy and safety of …

Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA …

A Ozdede, S Guner, G Ozcifci, B Yurttas… - Rheumatology …, 2022 - Springer
Most of the published data relate to classical forms of rheumatic diseases (RD) and
information on rare inflammatory disorders such as Behçet's syndrome (BS) and familial …